Conmed

Q2 FY2026 EarningsQ2 FY26 revenue was $343.5M, up 0.3% YoY as reported but down 0.5% in constant currency; however, organic constant currency growth was 6.0% after excluding strategic GI product exits. Adjusted diluted EPS rose 20.0% YoY to $1.38, supported by a $0.21 IEEPA tariff refund benefit. Gross margin expanded to 57.5% (GAAP) and 59.5% (Adjusted), while international sales surged 10.8% YoY. Full-year FY26 Adjusted EPS guidance was raised to $4.48–$4.60.